The Macromolecular Therapeutics Development Facility (MTDF) provides expertise for directed development and optimization of protein-based therapeutics and supports high-throughput automated development, analysis and production of protein reagents using a Bioemk FxP liquid handling workstation for HTP molecular biology and expression testing, a Perkin-Elmer Cell::Explorer robot for very efficient HTP tissue culture based application and a custom microarray printer. This automation is designed to provide Einstein researchers with the added leverage of robotics equipment and trained personnel to accelerate and scale up their projects, thereby obviating the need for individual investigators to set up and staff their own facilities for protein production.
Price Center/Block Research Pavillion 313
Steven C. Almo, Ph.D.
Director of Technology Development
James Love, PhD
Co-Scientific Director (Monoclonal Antibodies)
Matthew D. Scharff, M.D.
Associate Director (Monoclonal Antibodies)